Business

Boston Scientific announces conference call discussing first quarter 2026 results

Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2026, on Wednesday, April 22, 2026, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 22 prior to the conference call.

Boston Scientific CorporationMarch 30, 20261
Boston Scientific announces conference call discussing first quarter 2026 results

About this update from Boston Scientific Corporation

MARLBOROUGH, Mass. , March 30, 2026 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) will webcast its conference call discussing financial results and business highlights for the first quarter ended March 31, 2026, on Wednesday, April 22, 2026, at 8:00 a.m. ET. The call will be hosted by Mike Mahoney, chairman and chief executive officer, and Jon Monson, executive vice president and chief financial officer. The company will issue a news release announcing financial results for the first quarter on April 22 prior to the conference call. A live webcast and replay for the event will be accessible at https://investors.bostonscientific.com . The replay will be available approximately one hour following the completion of the event. About Boston Scientific Boston Scientific transforms lives through innovative medical technologies that improve the health of patients around the world. As a global medical technology leader for more than 45 years, we advance science for life by providing a broad range of high-performance solutions that address unmet patient needs and reduce the cost of healthcare. Our portfolio of devices and therapies helps physicians diagnose and treat complex cardiovascular, respiratory, digestive, oncological, neurological and urological diseases and conditions. Learn more at  www.bostonscientific.com  and follow us on  LinkedIn . CONTACTS: Chanel Hastings Media Relations +1 (508) 382-0288 [email protected] Lauren Tengler Investor Relations +1 (508) 683-4479 [email protected]   View original content to download multimedia: https://www.prnewswire.com/news-releases/boston-scientific-announces-conference-call-discussing-first-quarter-2026-results-302727378.html

View stock analysis, news, and events for Boston Scientific Corporation

Boston Scientific Corporationconference callMike Mahoneychief executive officerJon Monsonfinancial results

More from Boston Scientific Corporation

All Boston Scientific Corporation news →